|
Developmental Disabilities
|
F03.625.421 |
|
|
ras GTPase-Activating Proteins
|
D12.644.360.325.150.500 |
|
|
Orientia
|
B03.660.050.783.875.650.450 |
|
|
Rickettsieae
|
B03.660.050.783.875.650 |
|
|
Glucosylceramides
|
D09.400.410.420.525.200.250.490 |
|
|
Liliaceae
|
B01.650.940.800.575.912.250.618.875.500 |
|
|
Icodextrin
|
D05.750.078.562.622 |
|
|
Glucans
|
D05.750.078.562 |
|
|
Gonadotropins, Equine
|
D12.644.548.726.451 |
|
|
Purpura, Thrombotic Thrombocytopenic
|
C15.378.140.855.925.750.680 |
|
|
Purpura, Thrombocytopenic
|
C15.378.140.855.925.750 |
|
|
Medial Tibial Stress Syndrome
|
C26.558.705 |
|
|
Laryngostenosis
|
C08.360.591 |
|
|
Laryngeal Diseases
|
C08.360 |
|
|
Oligodeoxyribonucleotides, Antisense
|
D13.150.200.640 |
|
|
DNA, Antisense
|
D13.150.200 |
|
|
beta-Lipotropin
|
D12.644.548.365.935.480 |
|
|
Actinin
|
D12.776.210.500.095 |
|
|
Chlamydomonas reinhardtii
|
B01.650.940.150.385.650 |
|
|
Chlamydomonas
|
B01.650.940.150.385 |
|
